Global NK3 Receptor Antagonists Market Growth 2025-2031

Publication ID:

LPI08257294

Publication Date:

August 11, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global NK3 Receptor Antagonists market size is predicted to grow from US$ 285 million in 2025 to US$ 2626 million in 2031; it is expected to grow at a CAGR of 44.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
NK3 receptor antagonists are a class of drugs that inhibit the binding of neurokinin B (NKB) to the neurokinin-3 (NK3) receptor, primarily affecting the hypothalamic-pituitary-gonadal (HPG) axis. By modulating the pulsatile release of gonadotropin-releasing hormone (GnRH), these agents help regulate hormonal fluctuations and thermoregulation. NK3 receptor antagonists are being developed or used for the treatment of menopausal vasomotor symptoms (such as hot flashes), and are also under investigation for conditions like polycystic ovary syndrome (PCOS), sexual dysfunction, and certain neuropsychiatric disorders. Key examples include fezolinetant, and elinzanetant.
United States market for NK3 Receptor Antagonists is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for NK3 Receptor Antagonists is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for NK3 Receptor Antagonists is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key NK3 Receptor Antagonists players cover Astellas, Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淣K3 Receptor Antagonists Industry Forecast鈥� looks at past sales and reviews total world NK3 Receptor Antagonists sales in 2024, providing a comprehensive analysis by region and market sector of projected NK3 Receptor Antagonists sales for 2025 through 2031. With NK3 Receptor Antagonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NK3 Receptor Antagonists industry.
This Insight Report provides a comprehensive analysis of the global NK3 Receptor Antagonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NK3 Receptor Antagonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global NK3 Receptor Antagonists market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NK3 Receptor Antagonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NK3 Receptor Antagonists.
This report presents a comprehensive overview, market shares, and growth opportunities of NK3 Receptor Antagonists market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
30 mg Dose
45 mg Dose
Segmentation by Application:
Hospital
Specialty Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Astellas
Bayer
Key Questions Addressed in this Report
What is the 10-year outlook for the global NK3 Receptor Antagonists market?
What factors are driving NK3 Receptor Antagonists market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NK3 Receptor Antagonists market opportunities vary by end market size?
How does NK3 Receptor Antagonists break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NK3 Receptor Antagonists Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for NK3 Receptor Antagonists by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for NK3 Receptor Antagonists by Country/Region, 2020, 2024 & 2031
2.2 NK3 Receptor Antagonists Segment by Type
2.2.1 17 mg Dose
2.2.2 18 mg Dose
2.3 NK3 Receptor Antagonists Sales by Type
2.3.1 Global NK3 Receptor Antagonists Sales Market Share by Type (2020-2025)
2.3.2 Global NK3 Receptor Antagonists Revenue and Market Share by Type (2020-2025)
2.3.3 Global NK3 Receptor Antagonists Sale Price by Type (2020-2025)
2.4 NK3 Receptor Antagonists Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.5 NK3 Receptor Antagonists Sales by Application
2.5.1 Global NK3 Receptor Antagonists Sale Market Share by Application (2020-2025)
2.5.2 Global NK3 Receptor Antagonists Revenue and Market Share by Application (2020-2025)
2.5.3 Global NK3 Receptor Antagonists Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global NK3 Receptor Antagonists Breakdown Data by Company
3.1.1 Global NK3 Receptor Antagonists Annual Sales by Company (2020-2025)
3.1.2 Global NK3 Receptor Antagonists Sales Market Share by Company (2020-2025)
3.2 Global NK3 Receptor Antagonists Annual Revenue by Company (2020-2025)
3.2.1 Global NK3 Receptor Antagonists Revenue by Company (2020-2025)
3.2.2 Global NK3 Receptor Antagonists Revenue Market Share by Company (2020-2025)
3.3 Global NK3 Receptor Antagonists Sale Price by Company
3.4 Key Manufacturers NK3 Receptor Antagonists Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NK3 Receptor Antagonists Product Location Distribution
3.4.2 Players NK3 Receptor Antagonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for NK3 Receptor Antagonists by Geographic Region
4.1 World Historic NK3 Receptor Antagonists Market Size by Geographic Region (2020-2025)
4.1.1 Global NK3 Receptor Antagonists Annual Sales by Geographic Region (2020-2025)
4.1.2 Global NK3 Receptor Antagonists Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic NK3 Receptor Antagonists Market Size by Country/Region (2020-2025)
4.2.1 Global NK3 Receptor Antagonists Annual Sales by Country/Region (2020-2025)
4.2.2 Global NK3 Receptor Antagonists Annual Revenue by Country/Region (2020-2025)
4.3 Americas NK3 Receptor Antagonists Sales Growth
4.4 APAC NK3 Receptor Antagonists Sales Growth
4.5 Europe NK3 Receptor Antagonists Sales Growth
4.6 Middle East & Africa NK3 Receptor Antagonists Sales Growth
5 Americas
5.1 Americas NK3 Receptor Antagonists Sales by Country
5.1.1 Americas NK3 Receptor Antagonists Sales by Country (2020-2025)
5.1.2 Americas NK3 Receptor Antagonists Revenue by Country (2020-2025)
5.2 Americas NK3 Receptor Antagonists Sales by Type (2020-2025)
5.3 Americas NK3 Receptor Antagonists Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NK3 Receptor Antagonists Sales by Region
6.1.1 APAC NK3 Receptor Antagonists Sales by Region (2020-2025)
6.1.2 APAC NK3 Receptor Antagonists Revenue by Region (2020-2025)
6.2 APAC NK3 Receptor Antagonists Sales by Type (2020-2025)
6.3 APAC NK3 Receptor Antagonists Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe NK3 Receptor Antagonists by Country
7.1.1 Europe NK3 Receptor Antagonists Sales by Country (2020-2025)
7.1.2 Europe NK3 Receptor Antagonists Revenue by Country (2020-2025)
7.2 Europe NK3 Receptor Antagonists Sales by Type (2020-2025)
7.3 Europe NK3 Receptor Antagonists Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NK3 Receptor Antagonists by Country
8.1.1 Middle East & Africa NK3 Receptor Antagonists Sales by Country (2020-2025)
8.1.2 Middle East & Africa NK3 Receptor Antagonists Revenue by Country (2020-2025)
8.2 Middle East & Africa NK3 Receptor Antagonists Sales by Type (2020-2025)
8.3 Middle East & Africa NK3 Receptor Antagonists Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NK3 Receptor Antagonists
10.3 Manufacturing Process Analysis of NK3 Receptor Antagonists
10.4 Industry Chain Structure of NK3 Receptor Antagonists
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NK3 Receptor Antagonists Distributors
11.3 NK3 Receptor Antagonists Customer
12 World Forecast Review for NK3 Receptor Antagonists by Geographic Region
12.1 Global NK3 Receptor Antagonists Market Size Forecast by Region
12.1.1 Global NK3 Receptor Antagonists Forecast by Region (2026-2031)
12.1.2 Global NK3 Receptor Antagonists Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global NK3 Receptor Antagonists Forecast by Type (2026-2031)
12.7 Global NK3 Receptor Antagonists Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Astellas
13.1.1 Astellas Company Information
13.1.2 Astellas NK3 Receptor Antagonists Product Portfolios and Specifications
13.1.3 Astellas NK3 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Astellas Main Business Overview
13.1.5 Astellas Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer NK3 Receptor Antagonists Product Portfolios and Specifications
13.2.3 Bayer NK3 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂